Expanding the Frontiers of Type I PRMT Inhibitors: Novel Applications in Agriculture, Livestock, Water Purification, Invasive Species Control, and Food Preservation
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of Type I PRMT inhibitors, originally developed for treating neurological disorders, to tackle pressing challenges in diverse industries, including agriculture, livestock, water purification, invasive species control, and food preservation.
Background and Problem Solved
The original patent focused on the treatment of ALS and FTD by inhibiting dipeptide repeat proteins. However, the limitations of the original patent lie in its narrow scope, failing to explore the vast potential of Type I PRMT inhibitors in other fields. This inventive concept addresses this gap by applying the core technology to novel applications, solving problems such as crop yield instability, livestock disease susceptibility, water contamination, invasive species proliferation, and food spoilage.
Detailed Description of the Inventive Concept
The new claims describe systems and methods that integrate Type I PRMT inhibitors into various industrial processes. For instance, in agriculture, the inhibitor enhances crop resistance to environmental stressors, increasing yields. In livestock, it optimizes feed composition to promote growth and disease resistance. In water purification, the inhibitor improves membrane filter permeability and resistance to fouling. In invasive species control, it disrupts reproductive cycles. Finally, in food preservation, it extends shelf life by enhancing resistance to spoilage. These innovative applications harness the power of Type I PRMT inhibitors to drive significant improvements in respective industries.
Novelty and Inventive Step
The novelty of this inventive concept lies in its pioneering application of Type I PRMT inhibitors to entirely new fields, far beyond the original patent's scope. The inventive step is the recognition of the inhibitors' versatility and their potential to address pressing challenges in diverse industries, thereby opening up new avenues for innovation and commercialization.
Alternative Embodiments and Variations
Alternative embodiments of this inventive concept could include using Type I PRMT inhibitors in other industrial processes, such as bioremediation, biocatalysis, or biofuel production. Variations may involve combining the inhibitors with other technologies, like precision agriculture, IoT-enabled livestock monitoring, or advanced water treatment systems, to create even more sophisticated solutions.
Potential Commercial Applications and Market
The commercial potential of this inventive concept is substantial, with target markets including agriculture, livestock, water treatment, invasive species control, and food preservation. The ability to increase crop yields, enhance livestock growth, purify water, control invasive species, and extend food shelf life can have a significant impact on global industries, generating new revenue streams and opportunities for growth.
Original Patent Information
| Patent Number | US 11,857,534 |
|---|---|
| Title | Inhibition of dipeptide repeat proteins |
| Assignee(s) | ALS Therapy Development Institute |